Filter
1881
Filtered Results: 1881
Text search:
World
Health
Organization
WHO
and
World
Intellectual
Property
Organization
Featured
Recommendations
242
New Publications
378
Language
Document type
No document type
644
Studies & Reports
418
Guidelines
387
Manuals
227
Strategic & Response Plan
112
Training Material
52
Fact sheets
28
Situation Updates
7
Resource Platforms
4
Infographics
2
Countries / Regions
Global
161
India
36
South–East Asia Region
28
Africa
27
Western and Central Europe
27
Kenya
26
Ukraine
26
Uganda
24
South Africa
21
Ethiopia
21
Nepal
17
Ghana
17
Eastern Europe and Central Asia
16
Nigeria
14
Asia
13
Myanmar / Burma
13
Sierra Leone
12
West and Central Africa
12
East and Southern Africa
12
Bangladesh
12
Zambia
12
Syria
11
Malawi
11
Indonesia
11
Cambodia
10
Tanzania
10
Liberia
10
Rwanda
9
Middle East and North Africa
9
Western Pacific Region
8
Yemen
7
South Sudan
7
Lesotho
6
Afghanistan
6
Philippines
6
Eastern Europe
6
Thailand
5
Cameroon
5
Zimbabwe
5
Guinea
5
Mozambique
5
Latin America and the Carribbean
5
Congo, Democratic Republic of
5
Somalia
5
Pakistan
5
Iran
4
Haiti
4
Vietnam
4
Russia
4
Sudan
4
North Macedonia
3
Tajikistan
3
Kazakhstan
3
Laos
3
Burkina Faso
3
Germany
3
Lebanon
3
Sri Lanka
3
Colombia
2
Timor Leste/ East Timor
2
China
2
Kyrgyzstan
2
Peru
2
Venezuela
2
Lithuania
2
Jordan
2
Saudi Arabia
2
Côte d’Ivoire / Ivory Coast
2
Djibouti
2
Palestine
2
Georgia
2
Angola
2
Botswana
2
Iraq
2
Ecuador
2
North Korea
1
Mexico
1
Serbia
1
Turkey
1
Chile
1
Albania
1
Canada
1
Senegal
1
Estonia
1
Uzbekistan
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Armenia
1
USA
1
Paraguay
1
Japan
1
Denmark
1
Mauritius
1
Tunisia
1
Azerbaijan
1
Belarus
1
Bolivia
1
Papua New Guinea
1
Brazil
1
Namibia
1
Egypt
1
Greece
1
Mali
1
Chad
1
Libya
1
Bhutan
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
358
Clinical Guidelines
230
Public Health
168
Women & Child Health
139
Key Resources
135
Capacity Building
57
Pharmacy & Technologies
46
Toolboxes
Mental Health
187
HIV
152
COVID-19
149
Disability
141
TB
103
NTDs
91
Caregiver
90
Planetary Health
87
AMR
71
Global Health Education
57
2.0 Rapid Response
45
NCDs
43
Pharmacy
42
Conflict
42
Rapid Response
40
Malaria
38
Health Financing Toolbox
32
Refugee
20
Ebola & Marburg
19
Specific Hazards
10
Natural Hazards
8
Social Ethics
8
Polio
7
Zika
6
Cholera
3
Global Report on assistive technology
recommended
The report notes that the number of people in need of one or more assistive products is likely to rise to 3.5 billion by 2050, due to populations ageing and the prevalence of noncommunicable diseases rising across the world. The report also highlights the vast gap in access between low- and high-inc...
The Implementation toolkit for accessible telehealth services provides practical guidance to support governments, industry partners, health service providers and civil society groups in the use and implementation of the WHO-ITU Global standard for accessibility of telehealth services. The toolkit is...
This report compiles data for the first time on the far-reaching consequences of uncontrolled hypertension, including heart attacks, strokes and premature death, along with substantial economic losses for communities and countries. It also contains information on the global, regional and country-lev...
Implementation reference guide. This Malaria Surveillance Assessment Toolkit implementation reference guide is a comprehensive reference document, as well as a step by-step guide. It aligns and adapts available tools into a single set of standardized tools, which can be used to conduct malaria surve...
Saving lives is the priority of WHO’s response in Ukraine. WHO works to ensure time-critical, lifesaving multisectoral assistance, non-discriminatory access to emergency and essential health services and priority prevention programmes, and laying the foundation for longer-term health systems recov...
Rabies is fatal, vaccine-preventable disease responsible for an estimated 59,000 human deaths each year. Most cases are transmitted by dogs, and most deaths occur in underserved populations in Africa and Asia. Approximately 40% of deaths occur in children.
The goal of the strategy is to prevent seasonal influenza, control the spread of influenza from animals to humans, and prepare for the next influenza pandemic.
The new strategy is the most comprehensive and far-reaching that WHO has ever developed for influenza. It outlines a path to protect popul...
Evidence from a systematic review on antenatal zinc supplementation was evaluated as part of the World Health Organization (WHO) antenatal care (ANC) guideline development process in 2016, and the following recommendation on zinc supplementation was made: “Zinc supplementation for pregnant women i...
This document aims to provide global guidance on poliomyelitis (polio) surveillance in the context of the COVID-19 pandemic. It comes as a technical complement to Polio eradication programme continuity, Immunization in the context of COVID-19 pandemic frequently asked questions, and is aligned with ...
This update of the Guidelines for poison control, entitled Guidelines for establishing a poison centre, reflects the development of the role of poison centres in public health and the sound management of chemicals, described in section 1, and the opportunities provided by new technology. Assessments...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but also for the need to understand the current funding...
The present guidelines incorporate all these changes, leading to a substantial reconfiguration of therapeutic choices for both disease forms.
HAT is a serious, life-threatening disease and the efficacy of fexinidazole depends on swallowing the medicine after an appropriate intake of food as well as...
Operational guide: use of referral laboratories for the analysis of foodborne hazards in the Pacific
The Operational guide: use of referral laboratories for the analysis of foodborne hazards in the Pacific aims to strengthen the food analysis capacity of Pacific Island countries and areas by identifying national and reference laboratories capable of testing for priority foodborne hazards. The Pacif...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex...
The country profiles incorporate facts indicating the national status of medical devices in areas such as: medical device policies, regulations, incorporation, lists, inventories, nomenclature, health technology assessment, management, and biomedical engineering resources. This publication is int...
Developmental disabilities are common. Yet, children with developmental disabilities have been neglected in health systems planning and policy provisions for health and continue to experience stigmatization, institutionalization, barriers to access health care and inequalities in health and educatio...
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan...
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patterns are all influenced by gender.
Relapsing malaria caused by Plasmodium vivax parasites poses a significant challenge to global malaria elimination efforts. About one third of the population remains at risk of contracting P. vivax malaria, and 85% of P. vivax infections stem from reactivated latent parasites, leading to chronic ana...
